Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.Journal of Clinical Investigation, 2012, 122 (3), pp.1066-75. ⟨10.1172/JCI61226⟩
Journal articles
inserm-00869052v1
|
||
|
Targeting CD137 enhances the efficacy of cetuximab.Journal of Clinical Investigation, 2014, 124 (6), pp.2668-82. ⟨10.1172/JCI73014⟩
Journal articles
hal-01021651v1
|